Sergio Bernardini
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Physiology 67
- Clinical Laboratory Practices and Quality Control 37
- Alzheimer's disease research and treatments 15
-
- SARS-CoV-2 and COVID-19 Research 18
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 detection and testing 14
- Co-authors
- Giorgio Federici (67 shared papers)Marco Ciotti (30 shared papers)Massimo Ciccozzi (6 shared papers)Alessandro Terrinoni (35 shared papers)Giulia Maria Sancesario (37 shared papers)Marzia Nuccetelli (67 shared papers)Massimo Pieri (90 shared papers)Cheng-Bin Wang (1 shared paper)
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (29 papers)Clinica Chimica Acta (17 papers)International Journal of Molecular Sciences (13 papers)International Immunopharmacology (10 papers)Journal of Alzheimer s Disease (8 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Sergio Bernardini
456 papers receiving 14.4k citations
Sergio Bernardini's Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 660
- Infectious Diseases 1.1k
- Psychiatry and Mental health 859
- Physiology 1.0k
- Neurology 448
Countries citing papers authored by Sergio Bernardini
This map shows the geographic impact of Sergio Bernardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Bernardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Bernardini more than expected).
Fields of papers citing papers by Sergio Bernardini
This network shows the impact of papers produced by Sergio Bernardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Bernardini. The network helps show where Sergio Bernardini may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergio Bernardini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 478 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 949 | |
| 2 | 2011 | 366 | |
| 3 | 2013 | 319 | |
| 4 | 2017 | 292 | |
| 5 | COVID-19 Outbreak: An Overview Hit paper breakdown → | 2019 | 291 |
| 6 | 2014 | 286 | |
| 7 | 2013 | 274 | |
| 8 | 2016 | 201 | |
| 9 | 2013 | 191 | |
| 10 | 2007 | 185 | |
| 11 | 2011 | 183 | |
| 12 | Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside Hit paper breakdown → | 2022 | 183 |
| 13 | 2020 | 181 | |
| 14 | 2019 | 171 | |
| 15 | 2019 | 163 | |
| 16 | 2008 | 151 | |
| 17 | 2003 | 139 | |
| 18 | 2012 | 128 | |
| 19 | 2013 | 125 | |
| 20 | 2020 | 125 |
About Sergio Bernardini
Sergio Bernardini is a scholar working on Physiology, Infectious Diseases, Neurology, Molecular Biology and Pathology and Forensic Medicine, having authored 478 papers that have together received 14.8k indexed citations. Recurring topics across this work include Clinical Laboratory Practices and Quality Control (37 papers), SARS-CoV-2 and COVID-19 Research (18 papers), COVID-19 Clinical Research Studies (18 papers), Parkinson's Disease Mechanisms and Treatments (15 papers), Alzheimer's disease research and treatments (15 papers), SARS-CoV-2 detection and testing (14 papers), Multiple Sclerosis Research Studies (13 papers) and Sleep and Wakefulness Research (12 papers). The work is most often cited by research in Cancer Research (660 citations), Infectious Diseases (1.1k citations), Psychiatry and Mental health (859 citations), Physiology (1.0k citations) and Neurology (448 citations). Sergio Bernardini has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giorgio Federici, Marco Ciotti, Massimo Ciccozzi, Alessandro Terrinoni, Giulia Maria Sancesario, Marzia Nuccetelli, Massimo Pieri, Cheng-Bin Wang, Stefano Maria Cannata and Nicola Biagio Mercuri. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Clinica Chimica Acta, International Journal of Molecular Sciences, International Immunopharmacology and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.